Skip to main content

Table 2 Outcomes of pain control among the 3 groups

From: Effects of a fixed low-dose ropivacaine with different volume and concentrations on interscalene brachial plexus block: a randomized controlled trial

 

Group 0.75

Group 0.5

Group 0.25

P

NRPS in the PACU

0 (0–2)

0 (0–1)

0 (0–0)

0.581

NRPS 4 h after ISB

0 (0–2)

0 (0–1)

0 (0–3)

0.771

NRPS 8 h after ISB

0 (0–3)

0 (0–3)

0 (0–3)

0.211

NRPS 24 h after ISB

1 (0–6)

1 (0–5)

0 (0–7)

0.439

Worst pain score

3 (0–6)

3 (0–7)

3 (0–7)

0.882

Percentage of worst pain score over 4 (n,%)

11/33 (33 %)

6/29 (21 %)

12/33 (36 %)

0.372

Sleep disturbance because of pain (n,%)

6/33 (18 %)

2/29 (7 %)

5/33 (15 %)

0.416

Satisfaction score

9.2 ± 1.3

8.9 ± 1.2

9.4 ± 1.0

0.167

  1. Data are the mean ± SD, median (range) or numbers (incidence)